Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2014
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsantNichole Coleman, Hai M Nguyen, Zhengyu Cao, et al.
Molecular & Cellular Proteomics : MCP|June 27, 2024
Proximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in MicrogliaChristine A Bowen, Hai M Nguyen, Young Lin, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's DiseaseManikandan Samidurai, Karthick Chennakesavan, Souvarish Sarkar, et al.
World Journal for Pediatric & Congenital Heart Surgery|January 24, 2024
A 15-Year Experience With Total Anomalous Pulmonary Venous Connection in VietnamLe-Thanh Q Dinh, Giang T C Do, Thoi K Ngo, et al.
Science (New York, N.Y.)|October 14, 2017
Spaceborne detection of localized carbon dioxide sourcesFlorian M Schwandner, Michael R Gunson, Charles E Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2025
Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel K<sub>Ca</sub>3.1Seow Theng Ong, Young-Woo Nam, Joshua A Nasburg, et al.
Circulation Research|May 26, 2026
Targeting Arrhythmogenic Late Sodium Current by FHF1<sub>A</sub>-Derivative FixR in Heart Failure CardiomyocytesBence Hegyi, Paweorn Angsutararux, Nourdine Chakouri, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's diseaseSupriya Ramesha, Sruti Rayaprolu, Christine A Bowen, et al.
Pageof 5